" /> Peroxisome biogenesis disorder 4b - CISMeF





Preferred Label : Peroxisome biogenesis disorder 4b;

Symbol : PBD4B;

CISMeF acronym : PBD4B;

Type : Phenotype, molecular basis known;

Description : The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders (PBDs). The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012). For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539. Individuals with mutations in the PEX6 gene have cells of complementation group 4 (CG4, equivalent to CG6 and CGC). For information on the history of PBD complementation groups, see 214100.;

Inheritance : Autosomal recessive; Autosomal dominant;

Molecular basis : Caused by mutation in the peroxisome biogenesis factor 6 gene (PEX6, 601498.0007);

Laboratory abnormalities : Elevated spinal fluid protein; Elevated very long chain fatty acids (VLCFAs) in serum and fibroblasts; Catalase import deficiency; Random serum ACTH of 100 units; Low serum albumin;

Prefixed ID : #614863;

Details


You can consult :


Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.